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Bordetella pertussis is one of two Gram-negative bacteria responsible for causing whooping cough in 
humans, a highly contagious disease that infects the human upper respiratory tract. Whole-cell and 
acellular vaccines have been developed but due to side-effects resulting from whole-cell vaccines, 
acellular vaccines are currently preferred to prevent this disease. A second bacterium known to cause 
whooping cough is Bordetella parapertussis, but since it causes less aggressive symptoms, only B. 
pertussis is utilized in the manufacture of the vaccine. One acellular vaccine is based on four 
virulence factors: pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN), and 
fimbriae (FIM).  
The focus of this thesis was to explore the use of spectrofluorometry for monitoring and forecasting 
the performance of the upstream and downstream operations in the PRN purification process at 
Sanofi Pasteur.  The upstream fermentation process includes a series of reactors of increasing volume 
where the microorganism is grown under controlled conditions. The PRN purification process 
involves a series of sequential steps for separating this protein from other proteins for later use in the 
vaccine. The PRN is precipitated in three steps with ammonium sulphate at three different 
concentrations. The pellet is collected by centrifugation and dissolved in a buffer solution followed by 
chromatographic separation. The run-through is then ultra-filtered and diafiltered in two separate 
steps. The resulting concentrate is dissolved in water and subjected to another chromatographic step 
and diafiltration. The final filtration of PRN involves a pre-filtration and sterile filtration. Finally, the 
samples are collected for quality control. 
The objective of this work was to monitor the process at different steps of the upstream and 
downstream purification process by multi-wavelength fluorescence spectroscopy in combination with 
multi-variate statistical methods. From the spectra, it was possible to identify fluorescent compounds, 
such as amino acids and enzyme cofactors, without performing an additional pre-treatment or 
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purification step. Also, the identification of conformational changes in proteins and formation of 
complexes, such as NAD(P)-enzyme complex, was possible based on the shift in the emission peaks 
of the compounds identified. These results demonstrated the feasibility of using this tool for 
qualitative evaluation of the process. 
Multivariate methods, such as PCA and PLS, were used to extract relevant information and compress 
the fluorescence data acquired.  PCA was effective for correlating variability in the yield of pertactin 
to a particular fluorescence fingerprint. As a result of the study, it was concluded that a possible 
source of variability in the productivity that is observed might be a metabolic shift during the 
fermentation steps that leads to the accumulation of NAD(P)H (or NAD(P)H-enzyme complex) 
probably due to oxygen transfer limitations. This conclusion was reached after investigating changes 
in the dissolved oxygen, aeration, agitation, supplementation time and key metabolites (lactate, 
glucose, glutamine) profiles. The correlation of these parameters with low productivity it was not 
straightforward; however, some consistencies were observed, for example, high levels of glutamine in 
batches with low productivity. This fact might be related to the start of the supplementation time, 
which may be related to the dissolved oxygen, since the addition of the supplement is done manually 
when an increase of the dissolved oxygen is detected. It is believed that this factor is related to the 
low production of protein product, such as pertactin. 
By means of PLS, it was possible to build regression models that allow for predicting the final 
concentration of pertactin from the fluorescence measurements. The models were built using the new 
variables obtained from data compression performed with PCA, and the final pertactin concentration 
measured by a Kjeldahl test. With this method, two regressions were constructed: (i) between 
NAD(P)H-enzyme complex spectra from the fermenters and pertactin concentration and (ii) between 
the pertactin fluorescence spectra from the last step of purification and pertactin concentration. A 
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third model was built using the protein content, the NAD(P)H-enzyme complex content in the 
fermenters and pertactin concentration.  
Attempts were made to identify the possible enzyme that may bind to NAD(P)H, assumed to be a 
dehydrogenase. Substrates for different enzymes were employed with the objective of measuring 
changes in the fluorescence of the characteristic peak for this binding (Ex/Em=280/460 nm). Major 
changes were detected after addition of the substrates oxaloacetate, ubiquinone and succinate 
dehydrogenase. Since changes were detected with more than one substrate, it was not possible to 
unequivocally identify the enzyme; however, the results provide some insight into what may be 
happening at the metabolic level.   
The work carried out in this thesis involved both analysis of samples provided or collected by the 
industrial sponsor as well as analysis of samples prepared at the University of Waterloo for 
measurement, interpretation and calibration. The proposed fluorescence-based method was found 
suitable for assessing protein quantity as well as for providing an indication of possible protein 
aggregation and conformational changes. Future work will be required to identify the exact source of 
variability in the production of pertactin, by means of monitoring the evolution of fermentation, 
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Chapter 1  
Introduction 
1.1 Research Motivation  
Whopping cough is a bacterial infection of the lungs, characterized by severe coughing fits. 
Bordetella pertussis is one of the causative agents of this condition.  To prevent this disease,  whole-
cellular and acellular vaccines have been developed, but due to side effects associated to the whole-
cellular vaccines, acellular vaccines are preferred even though are less effective (Thalen, 2008). 
Current acellular vaccines are based on virulence factors: pertussis toxin (PT), filamentous 
hemagglutinin (FHA), pertactin (PRN), and fimbriae (FIM). Not all vaccines contain the four listed 
virulence factors; some of them are based on just two antigens. 
In this project, the upstream fermentation process and the downstream purification of PRN were 
monitored and evaluated using spectrofluorometry in combination with multivariate statistical based 
models. Process monitoring is essential for understanding the sources of variability of a 
biotechnological process. Having an appropriate insight into the process, allows optimizing and 
increasing productivity (Marose et al., 1998). The use of fluorescence spectroscopy has been reported 
for biomass detection, characterization of reactors and bioprocess monitoring (Manrose et at., 1998; 
Lindemann et al., 1998; Skibsted et al., 2001; Hagedorn et al., 2002). Since a wide range of 
excitation-emission wavelength can be monitored using fluorescence spectroscopy, several 
fluorophores, such as proteins, vitamins and coenzymes, can be detected simultaneously (Lindemann 
et al., 1998). However, spectral overlap, noise, strong correlations among data and complex 




analysis was used to extract the most important information associated with the properties of the 
system being studied. First principal component analysis (PCA) was used to compress the data. The 
resulting compressed data for different stages of the process was analyzed for identifying sources of 
variability in productivity.  Then, the partial least squares’ approach (PLS) was used for correlating 
the fluorescence spectra and the final protein content of PRN as measured by a Kjeldahl test.  
1.2 Description of the upstream fermentation and downstream purification process 
Figure 1.1 shows a flow diagram of the upstream and the downstream purification process of 
pertactin (PRN) which is the antigen of interest for the current work. 
The upstream process is started by thawing a frozen Component Pertussis seed. Then, the thawed 
culture is transferred to seed flasks containing liquid medium which are incubated for 48 to 96 hours. 
Following incubation, the cultures are added to two seed 20 L fermenters (initial fermentation stage) 
containing mainly Component Pertussis broth and growth factors. The seed fermenter cultures are 
grown for 22 to 25 hours. Subsequently, the cultures are transferred to two 200 L fermenters 
(intermediate fermentation stage) for 22 to 25 hours, and then to two 2000 L fermenters (production 
fermentation stage) for up to 56 hours. All fermenters work under the same operating conditions in 
terms of temperature (36ᵒC), dissolved oxygen (35%) and pH (7.2) levels, which are continuously 
monitored and controlled in closed loop.  In the production fermenters, supplement is added when the 
initial supply of nutrients is exhausted. The depletion of nutrients is detected by a significant sudden 





These fermentation steps are followed by harvesting, which involves the centrifugation of the 
fermentation culture. The cell paste, coming from the centrifugation, is collected into a tank for 
further fimbria (FIM) purification, and the supernatant to be referred as centrate is filtered to ensure 
the complete removal of the live cells. 
In the downstream process, the filtered centrate, which contains PT, FHA and PRN, is further 
concentrated by using 10-kDa cellulose membranes. Following this, a perlite fractionation is used in 
the initial separation of three antigens which are needed for the acellular vaccine formulation in 
addition to FIM: pertactin (PRN), filamentous haemogglutinin (FHA) and pertussis toxin (PT). PRN 
is collected in the runthrough of the column used in this separation step, while PT and FHA are eluted 
off the column.  
After this step, PRN is precipitated in three consecutive precipitation steps using ammonium sulphate 
at three different concentrations. In the first and third precipitation, the pellet is the fraction of interest 
while in the second precipitation the supernatant is used. The final pellet collected by centrifugation is 
dissolved in 10 mM HCl Tris buffer and loaded onto a chromatography column. Finally, the product 
is ultrafiltered and diafiltered before being subjected to a final chromatography step. The final 
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After the purification process, PRN is adsorbed onto aluminum phosphate, which acts as an adjuvant. 
Adjuvants are compounds that serve to enhance the immune system in response to an antigen 
(Lindblad, 2004). In the adsorption process, an aluminum phosphate solution is added to the antigen, 
and mixed for 4 days at 16ºC to 24ºC. After the adsorption, PRN is stored at 2ºC to 8ºC up to 36 
months.    
1.3 Research Objectives 
The main objective of this thesis is to monitor and evaluate the upstream and downstream purification 
process of PRN as a component in the manufacturing of the whooping cough vaccine at Sanofi 
Pasteur (Figure 1.1) by employing multi-wavelength fluorescence in combination with multi-variate 
statistical methods. The specific objectives are the following:   
1. Obtain reproducible fluorescence spectra for different steps in the PRN manufacturing 
process. By acquiring fluorescence measurements, it is possible to identify fluorescent 
compounds present in the samples simultaneously, and to track changes of these compounds 
through the process. 
2. Develop a fluorescence-based calibration model to identify changes in the antigen 
manufacturing process. Since spectra can overlap and the existence of noise can render 
difficult data interpretation, it is necessary to use statistical methods to extract the most 
important information from the measurements.   
3. Assessment of parameters, such as temperature, that can influence protein degradation during 
storage.  
4. Examine the feasibility of applying spectrofluorometry to surface phosphophilicity 




antigens used in vaccines formulation. Changes in the fluorescence spectra could be 
indicative of variation of adsorption of antigens on the adjuvant.   
1.4 Thesis Structure 
This thesis includes five chapters. The current chapter contains the description of the process and 
research objectives. Chapter 2 presents the theoretical background about whooping cough and 
vaccines, fluorescence, instrumentation, uses of spectrofluorometry in biological processes, and 
multivariate methods. Chapter 3 explains the materials and methods employed in the three main 
analyses that were performed in this thesis: fluorescence data acquisition and analysis of the upstream 
and downstream pertactin purification process, enzyme assay and surface phosphophilicity assay. 
Chapter 4 presents the results and discussion for data acquisition, data compression, and regression 











Chapter 2  
Literature Review 
2.1 Whooping Cough  
Whooping cough, or pertussis, is a contagious infection of the lungs and airways. In humans, one of 
the causative agents of this illness is the gram-negative bacterium Bordetella pertussis, which was 
first isolated by Bordet and Gengou in 1906. The name pertussis means “violent cough” (Hijnen, 
2008). This disease happens year round everywhere in the world.  Each year in Canada an average of 
2,000 people fall ill from whooping cough, and worldwide, there are around 20 to 40 million cases 
and 400,000 deaths from this condition each year. Symptoms are initially mild, and then develop into 
severe coughing fits, which produce the namesake high-pitched "whoop" sound when air is inhaled 
after coughing. Without treatment, whooping cough can last weeks or months, and can cause brain 
damage or even death. It is most dangerous for children under 1 year in age, especially if they are 
unvaccinated or under-vaccinated (Public Health Agency of Canada, Pertussis (whooping cough), 
Canada. Last Date Modified: 21 February 2014 <http://www.phac-aspc.gc.ca/im/vpd-mev/pertussis-
eng.php>) 
Aside from  Bordetella pertussis, there are several other pathogenic species in the genus Bordetella 
that can cause upper respiratory tract infections. B. parapertussis causes a mild whooping cough-like 
syndrome, whereas B. bronchiseptica, an animal pathogen, is isolated rarely from humans (Locht, 
1999). Since B. parapertussis causes less severe symptoms, all vaccines are based on B. pertussis 




The creation of vaccines started immediately after the isolation of B. pertussis. In the early 1930s, the 
first mono component whole-cell pertussis vaccines were prepared (Hijnen, 2006), and in 1947 started 
the production of combination vaccines, where pertussis vaccines were combined with diphtheria and 
tetanus toxoids (DTP). Mortality was reduced in 10-fold with the introduction of these vaccines 
(Hijnen, 2006).  
Although the whole cell vaccines were highly effective, they had drawbacks related to the side-effects 
(Hijnen, 2006; Thalen, 2008). Symptoms such as fever and more serious events such as convulsions 
were believed to be due to the lipo-polysaccharide (LPS) in the outer membrane of B. pertussis. For 
this reason, the manufacture of acellular vaccines that only consist of one or more B. pertussis 
antigens was necessary.  During the 80’s and 90’s, the development of acellular vaccines started, 
which replaced the previous whole-cell vaccines (Thalen, 2008). Even though acellular vaccines are 
less effective than whole-cell vaccines, they are less likely to provoke side effects (Thalen, 2008). 
Typically acellular pertussis vaccines contain at least two of four purified and detoxified B. pertussis 
antigens: pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN) and fimbriae 
(FIM2 and FIM3). The selection of these antigens was based on the strong immune response 





Figure 2.1 Schematic representation of B. pertussis antigens that are components of acellular 
whooping cough vaccines (adopted with modifications from Thalen, 2008) 
 
Antigens or virulence factors are proteins used by a pathogen to enter the host and allow interaction 
with a specific target cell.  Ultimately the pathogen must evade the host defenses to survive, damage 
the cell host and propagate either itself or its products to cause disease (Noofeli, 2007). 
Many of the virulence factors characterized for the Bordetellae are common to many members of this 
genus including B. pertussis, B. parapertussis and B. bronchiseptica. These factors consist of 
adhesins (needed for the attachment to the host cells) that include filamentous hemagglutinin (FHA), 
tracheal colonization factor and fimbriae (FIM), pertactin (PRN), and toxins, such as adenylate 
cyclase haemolysin, dermonecrotic toxin and tracheal cytotoxin (Figure 2.1). However, there are 
other virulence factors which are expressed by just one of the species, such as pertussis toxin and 
serum resistance to killing protein (BrkA), which are expressed only by B. pertussis (Noofeli, 2007). 
Fimbriae (FIM) 
Pertussis Toxin (PT) 
Pertactin (PRN) 




Pertussis toxin (PT) is one of the major protein toxins secreted by B. pertussis. It is released into the 
extracellular milieu and remains cell-bound. PT is a 105 kDa hexamer consisting of five subunits 
which are responsible for the interaction of the toxin with the target cell receptors (Locht, 1999). 
Fimbriae are submicroscopic proteinaceous appendages that protrude from the cell surface. They are 
comprised of two major subunits: Fim2 (22.5 kDa) and Fim3 (22 kDa) (Noofeli, 2007). These units 
bind to sulphanated sugars that are present in the respiratory tract (Badu et al., 2001).   
Filamentous hemagglutinin (FHA) is a major adhesin of B. pertussis and facilitates adherence of the 
cells to the respiratory epithelial cells. It is a filamentous structure about 2 nm wide and 50 nm long, 
and has a molecular weight of 220 kDa (Badu et al., 2001). 
Pertactin (PRN) is an outer membrane protein partly responsible for adhesion of the bacterium to the 
host cell. This antigen was initially referred to as P69 or 69-kDa protein because of its apparent 
molecular weight as determined by sodium dodecyl sulphate polyacrylamide gels (SDS-PAGE). 
However, it was characterized by other methods such as mass spectroscopy (MS), the molecular 
weight was found to be approximately 60 kDa (Charles et al., 1994; Noofeli, 2007).   
PRN belongs to the family of extracellular proteins called autotransporters (AT) found in various 
Gram-negative bacteria. The autotransporter secretion, or type V secretion, is one of the mechanisms 
developed by Gram-negative bacteria to achieve their physiological goals i.e. surface motility, host 
invasion (Henderson et al., 1998).  The name autotransporter derives from an initial understanding 
that the protein is self-sufficient in transporting the passenger domain (stable units of protein structure 
that could fold autonomously) through the outer membrane present only in Gram-negative bacteria.  




sequence (N-terminal), the secreted mature protein (passenger domain) and a carboxyl terminal (C-
terminal) (Henderson et al., 1998) as depicted in Figure 2.2. 
 
Figure 2.2 Autotransporter structure (adopted with modifications from Junker et al., 2006) 
 
Virulence factors production and their interaction to the cell, as well as bacteria growth rate, are 
influenced by the cultivation conditions for the bacterium and the composition of the employed in the 
fermentation (Thalen, 2008). Small changes in the conditions, such as changes in composition, pH, 
temperature, and pressure can alter cell metabolism and have a significant impact in the subsequent 
purification steps and therefore, in productivity of the protein product (Vojinović et al., 2006). 
In the manufacture of acellular vaccines, not only does the production and selection of antigens play 
an important role, but also the selection of components that improve the efficacy of vaccines, such as 
the vaccine adjuvants. 
2.2 Vaccine adjuvants  
Adjuvants are components that potentiate the immune response to an antigen. Aluminium adjuvants 
are the most widely used adjuvants in both human and veterinary vaccines (Lindblad, 2004). These 







phosphate (Zhao et al., 2001). Although many other adjuvants have been proposed over the years, 
these have failed to be successful in humans largely because of toxicity, stability and cost (Petrovsky 
et al., 2004). 
Adjuvants are used in vaccine formulations for many reasons: (i) to improve the efficacy of vaccines; 
(ii) to decrease the quantity of antigen needed; (iii) to modulate immune response; or (iv) as antigen 
delivery systems (Petrovsky et al., 2004). 
Aluminum adjuvants are commonly employed in Diphtheria, Tetanus, Pertussis and Hepatitis A and 
B vaccines. It enhances antibody responses; however, its mechanism of action is still unknown. It has 
been proposed that alum acts as a delivery system by generating depots that trap antigens, providing 
slow release in order to allow a longer exposure of the antigen, and therefore the stimulation of the 
immune system (Tritto et al., 2009). 
Aluminum adjuvants have a high affinity to phospho-containing species, both organic and inorganic. 
Since many antigens contain phosphoryl groups, they can bind to the aluminum-containing adjuvant. 
This ability has been denoted by some authors as “phosphophilicity”, and its study has gained a broad 
interest in vaccine development as well as in vaccine and adjuvant manufacturing (Zhao et al., 2001). 
2.3 Process Monitoring and Control 
The monitoring and control of processes have a crucial role in all industries to maintain maximum 
efficiency and desired product quality. For instance, in pharmaceutical processes, e.g. vaccine 
production, the cultivation of cells requires among other factors, complex media composition, 




productivity. Therefore, efforts in sensor design, sampling strategies, and data management have been 
made to improve process monitoring (Pohlscheidt et al., 2013). 
2.3.1 Methods of Monitoring 
Depending on the location where the samples are analyzed, methods for analysis can be classified in 
the following categories: 
2.3.1.1 Off-Line Monitoring 
In off-line monitoring, samples are withdrawn from the process and analyzed in a suitable device 
(Elshereef, 2009; Pohlscheidt et al., 2013). By doing sampling, it is possible to evaluate the overall 
state of the process at a certain time. Even though this approach allows high precision measurements, 
off-line analytics always has a delay between the sampling and the measurements (Vojinović et al., 
2006). Handling and preparation of the sample can have a significant impact in the accuracy of the 
measurement. For instance, aseptic treatment and mixing after sampling are important aspects to be 
considered before analysis (Pohlscheidt et al., 2013). 
Traditional laboratory techniques are usually implemented in off-line monitoring (Elshereef, 2009). 
For process control, measuring of metabolites are essential to maintain, characterize and further 
improve fermentation processes. Methods such as enzyme linked immunosorbent assay (ELISA) and 
high performance liquid chromatography (HPLC) are conventionally used in the analysis of specific 
proteins and substrates. Enzyme-based biosensors, e.g. bioprofiles, are usually employed to measure 




2.3.1.2 In Situ or In-Line Monitoring 
In this type of monitoring, sensors are directly positioned in the vessel or in the flow line, and no 
withdrawal of sample is needed. Chemical and physical parameters, such as pH, redox potential, O2, 
CO2, conductivity, and turbidity, are usually monitored in situ. The advantage of in situ monitoring 
over offline monitoring, is the rapid measurement and direct control (Pohlscheidt et al., 2013). 
This type of monitoring is sometimes called on-line monitoring. Some authors make a differentiation 
between these two terms, naming on-line monitoring when a sample is automatically withdrawn and 
analyzed.  
2.3.1.2.1 In Situ Process Monitoring Using Spectrometry 
Several technologies are being developed for real-time estimation of nutrient levels. Technologies 
including Raman spectroscopy, infrared spectroscopy, UV spectroscopy, and fluorescence 
spectroscopy can monitor a wide array of species, including glucose, lactate, various amino acids, and 
NAD(P)H. (Pohlscheidt et al., 2013). 
Fluorescence spectroscopy (also known as fluorometry or spectrofluorometry) is a type of 
electromagnetic spectroscopy which analyzes fluorescence from a sample. It involves using a beam of 
light, usually ultraviolet light, that excites the electrons in molecules of certain compounds and causes 
them to emit light. 
The key characteristic of fluorescence spectrometry is its high sensitivity. Fluorometry may achieve 
limits of detection several orders of magnitude lower than those of most other techniques. Limits of 




detection limits, fluorescence is widely used for quantification of trace constituents of biological and 
environmental samples. Fluorometry is also used as a detection method in separation techniques, 
especially liquid chromatography and electrophoresis (Wehry, 1997). 
Interpretation of fluorescence spectra sometimes can be difficult due to the overlapping spectra of 
multiple species. Methods for data compression such as principal component analysis (PCA) and 
partial least squares (PLS) are commonly used to identify correlations among fluorescence spectra 
and to reduce them into small number of orthogonal variables (Pohlscheidt et al., 2013). 
2.4 Principles of Fluorescence Spectroscopy 
Fluorescence is a type of luminescence in which molecules emit light from electronically excited 
states generated by a physical (e.g. absorption of light), mechanical (friction), or chemical 
mechanism. When luminescence is generated through excitation by ultraviolet or visible light, the 
phenomenon is termed photoluminescence, and is formally divided into two categories: fluorescence 
and phosphorescence, depending on the electronic configuration of the excited states and the emission 
pathways (Lakowicz, 2006; Wehry, 2007). 
2.4.1 Fluorophores 
Fluorophores are compounds that can re-emit light upon excitation. Fluorescent compounds have two 
characteristic spectra: an excitation spectrum (amount of light absorbed) and an emission spectrum 
(amount of light emitted).  
Fluorophores are divided into two classes: intrinsic, which occur naturally, and extrinsic, which are 




acids: tryptophan (Trp), tyrosine (Tyr), and phenylalanine (Phe). The indole ring (Figure 2.3) of 
tryptophan is the most dominant fluorophores in proteins (Lakowicz, 2007). 
 
Figure 2.3 Fluorescent amino acids (adopted with modifications from Lakowicz, 2007) 
 
Tryptophan residues inside the protein can be found in different locations (buried in nonpolar regions 
or in the surface), therefore they are not influenced by the environment in the same manner (Burstein 
et al., 1973). Depending on the location, tryptophan residues can emit from 308 to 352 nm. When the 
Trp residues are buried in non-polar regions of the protein, less energy is lost to the environment and 
a blue-shift in the emission spectra is observed. As the residues are located closer to the surface and 
more exposed to the environment, the emission spectra is shifted to higher wavelengths (red-shift), 
reaching the maximum emission when the protein is unfolded (Burstein et al., 1973; Lakowicz, 
2007).    
The emission wavelengths of phenylalanine overlap with the absorption wavelengths of tyrosine. In 
turn, the emission wavelengths of tyrosine overlap with the emission of tryptophan (Devlin, 2006). 
Because of these overlaps, energy absorbed by phenylalanine and tyrosine is transferred to 
tryptophan, and only the emission of tryptophan is observed in proteins (Devlin, 2006; Lakowicz, 
2007).  
   
Indole  






Energy transfer occurs when distance between donor and acceptor are up to 80 Å. When a protein is 
denatured, this distance increases and the energy transfer among fluorophores is inefficient (Devlin, 
2006).   
Tryptophan, tyrosine and phenylalanine absorb UV light at two different wavelengths. The peak at 
excitation next to 280 nm is the result of the absorbance by the aromatic ring portion of their 
structure. The peak at lower wavelengths is caused by absorbance of peptide and carboxylic acid 
moieties in the compounds (Figure 2.3) (Held, 2013).     
In protein fluorescence analysis, the intensity values under excitation (Ex) 250 nm, usually are not 
taken into account if the experiment is done in aerial conditions. Since oxygen absorbs at this range, 
dissolved oxygen should be removed before any fluorescence measurement by passing inert gas 
through the sample. 
In Table 2.1, excitation-emission values of aromatic amino acids in water are shown: 
Amino acid λex (nm) λem (nm) 
Phenylalanine 260 282 
Tyrosine 275 304 
Tryptophan 295 353 
 
Table 2.1 Excitation-emission values of aromatic amino acids in water at neutral pH (Lakowicz, 
2007) 
    




Among biological molecules, fluorescence is observed in co-factors such as reduced nicotinamide 
adenine dinucleotide (NADH), from oxidized flavins (FAD, the adenine dinucleotide, and FMN, the 
mononucleotide) (Lakowicz, 2007). NADH absorbs light at two excitation wavelengths: 260 nm and 
340 nm, with an emission wavelength at 460 nm. The excitation at 260 nm is due to the adenine 
group and the peak at 340 nm corresponds to the absorption by the pyridine ring (Figure 2.7) (Rover 
et al., 1997). Also, NADPH has the same Ex/Em as NADH (Lakowicz, 2007). 
Flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) absorb light at Ex~450 nm and 
emit at Em~525 nm (Lakowicz, 2007).  
The fluorescence properties of these cofactors have been employed to study their binding to proteins. 
When bound to an enzyme, NAD(P)H is in an extended conformation, which prevents quenching of 
the pyridine ring by the adenine group (Figure 2.4). As a result, the emission intensity is higher in this 
case compared when free in solution. Also, due to the binding, there is a quenching of tryptophan 
present in the protein (Lakowicz, 2007). A binding enzyme-cofactor also results in a shift in the 
emission of NAD(P)H from 260 nm to 280 nm (Gazzotti et al., 1974). In contrast to NAD(P)H, 






Figure 2.4 Biochemical fluorophores. R is a hydrogen in NADH, and a phosphate group in NADPH 
(adopted with modifications from Lakowicz, 2007) 
 
Extrinsic fluorophores can be used to measure enzyme activities. The simplest approaches are those 
in which a fluorescent substrate is converted into a nonfluorescent product, or a nonfluorescent 
substrate is converted into a fluorescent product after enzymatic cleavage. The enzyme activity is 
monitored by following the decrease or the increase in fluorescence intensities respectively 
(Deshpande, 2001). 
 
2.4.2 Theory of Fluorescence 
When a fluorophore is irradiated by a light source with a wide spectrum of wavelengths, it will absorb 











occur, depends on the electronic configuration of the molecule. This configuration is unique to each 
fluorophore, which made each fluorescence spectra also unique. 
The process, in which the absorption and emission of light can occur, is illustrated by a Jablonski 
diagram. A simplified Jablonski diagram is shown in Figure 2.5-A. The ground, first and second 
electronic states are represented by S0, S1 and S2, respectively. The vibrational energy levels, in 
which a fluorophore might exist, are indicated by 0, 1, 2, 3, and 4. The vertical lines represent the 




Figure 2.5 Jablonski diagram; B: Simplified operating diagram for a spectrofluorometer (adopted 




A simplified operating diagram of a spectrofluorometer is shown in Figure 2.5-B. A 
spectrofluorometer is an instrument that allows measuring quantitatively fluorescence from a sample. 
It consists of a light source coupled to an excitation monochromator that irradiates the sample in a 
cuvette. Light emitted by the sample is then collected by an emission monochromator which 
illuminates a detector (Longworth, 1968).   
2.4.3 Variables of Fluorescence Measurements 
Fluorescence intensities are typically directly proportional to concentration. There are, however, 
variables that affect this linearity such as quenching, the molecular environment of fluorophores and 
light scattering.  
2.4.3.1 Quenching 
This term refers to factors that reduce intensities of fluorescence: 
- High concentration. When concentration is too high, the light cannot pass through the sample 
to cause excitation; thus very high concentrations can have very low fluorescence.  
- Collisions with other molecules. It results in the loss of excitation energy as heat instead of as 
emitted light.  
- Formation of a complex between the fluorophore and the quencher (static quenching). A 
special case of static quenching is self-quenching, where fluorophore and quencher are the 
same species. Self-quenching is particularly evident in concentrated solutions.  
- Resonance energy transfer. In this case, the two participating molecules do not have to collide 




transferred to another molecule, without emitting light.  As a result, the acceptor remains 
excited while the donor stays in the ground state.  
2.4.3.2 Molecular Environment 
The fluorescent amino acids present in protein consist of hydrophobic amino acid residues, which are 
sensitive to the local environment. Due to this, changes in the emission can be detected depending on 
the exposure of the amino acid residues to the environment, and therefore information about 
denaturation or protein conformation can be obtained from fluorescence measurements (Lakowicz, 
2007) 
2.4.3.3 Light Scattering 
The light scattering effects are called Rayleigh scattering (first and second order) and Raman 
scattering. The first order Rayleigh scattering is observed when the emission wavelength equals the 
excitation wavelength (λem=λex). In second order Rayleigh scattering, the emission wavelength equals 
twice the excitation wavelength (λem=2λex), and the Raman scattering dependent upon the solvent of 
the sample (Rinnan et al., 2005).    
Rayleigh scattering might interference in the fluorescence emission of fluorophores (Christensen et 
al., 2006). Since it is difficult to eliminate such as interference, mathematical corrections can be made 
to analyse the fluorescence data. Due to its weak contribution, Raman scattering is dismissed 




2.5 Multivariate Analysis of Fluorescence Excitation-Emission Matrices 
Multivariate analysis is the application of multivariate statistics to analyze data that arises from more 
than one variable. The most common data analytical approaches are Principal Component Analysis 
(PCA), used for exploring, visualizing and reducing data dimension, and Partial Least Square 
regression (PLS), used to construct models that allow predicting a certain variable from a measured 
spectra (Christensen et al., 2006). 
2.5.1 Pre-processing of data 
Prior to performing any multivariate analysis, the raw data must be pre-processed to ensure that the 
data are symmetrically distributed. The common methods to pre-process data are the following: 
- Mean centering: calculates the mean of each variable in a set of data and subtracts the mean 
from each variable to make the new mean equal to zero. 
- Median centering: similar to mean centering. In this case, the median is used instead of the 
mean. 
- Auto-scaling: variables are mean centered and scaled to unit variance 
2.5.2 Principal Component Analysis (PCA) 
PCA is one of the methods employed for data compression and extraction of the most important 
information from a data set (Abdi et al., 2010). PCA reduces the original variables into a lower 
number of orthogonal (non-correlated) variables (PC’s).  
These PC’s are linear combinations of the original variables (e.g. fluorescence intensities) that capture 




describe a significant percentage of the variability is kept for further analysis whereas the remaining 
PC’s are discarded on the assumption that they correspond to noise.  
A graphic example of how PCA works is shown in Figure 2.9. Having a 3D space with variables X1, 
X2 and X3, the goal is to find a vector that captures the maximum variability (or minimizes the loss of 








One can project any point on the vector (e.g. Pi) by multiplying the three coordinates of the point by 
the normalized vector u. In this sense, a point of three dimensions is reduced to one dimension. In 
PCA, the goal is to maintain the distance between the points and the new vector (PC) as small as 
possible: 
∑  −  = 
                                                                (2.1) 




PCA is an iterative process. When the first PC is found, the remaining variability should be explained 







For finding the second PC, the method rotates the axes of the first PC to find an orthogonal plane, and 
in this manner find the second PC that captures the remaining variability.  
PCA decomposes a set of data (matrix X) as the sum of the products of vectors si and pi, plus a 
residual matrix E (Equation 3.1).  
 = ∑  ∗  +                                                             (2.2) 
Where n is the number of samples. The si vectors are known as scores and contain information on 
how the samples relate to the principal components, and can be interpreted as the projections of the 
original variables on the new space. The pi vectors are known as loadings and contain information on 
how the original variables relate to each other along the principal components. 




While PCA performs data compression on the input data only, i.e. fluorescence intensities, other 
multivariate statistical methods are needed to correlate the input data to other measured data. Partial 
Least Squares (PLS) is a multivariate regression method that correlates the information in one data 
matrix (X) to the information in another matrix (Y). PLS is used to obtain a regression model between 
X to Y so that newly acquired values of X could be used to predict Y. 
2.5.2 Partial Least Square (PLS) 
PLS performs data compression and extracts a small number of latent (not directly measured) 
variables (LVs) that describes the observed or measured data. In contrast to PCA, PLS not only finds 
the major variations in X and Y, but identifies the latent variables that correlate the scores in the X 
matrix with the scores in the Y matrix to have maximum covariance. 
In this sense, PLS decomposes X and Y matrix as follows: 
 =  +  = ∑  ∗  +                                                      (2.3) 
 =  +  = ∑  ∗   +                                                      (2.4) 
Where m is the number of latent variables. The ti and ui vectors are the scores and contain 
information on how the samples relate to the latent variables. Scores in T are the projections of the 
input data X to a LV in the X-space, and scores in U are the projections of the response data to a LV 
in the Y-space. The qi and ci vectors are known as loadings and represent the relationship between T 
and X-space, and U and Y-space respectively. E and F contain the variables left unexplained by the 
model.  




 = !                                                                  (2.5) 
Where W is the weight matrix. From equation 2.5, it is possible to predict the scores in Y from scores 

















Chapter 3  
Materials and Methods 
In this chapter, the materials and methods are organized according to the three main analyses that 
were performed in this thesis: fluorescence data acquisition and analysis various steps of the upstream 
and downstream pertactin purification process, enzyme assay and surface phosphophilicity assay. 
3.1 Fluorescence analysis of the upstream and downstream pertactin purification 
process 
3.1.1 Samples  
Samples were provided by Sanofi Pasteur (Toronto, Ontario, Canada) from upstream and downstream 
steps for different batches conducted during the period shown in Table 3.2. For the upstream part of 
the process, there are two parallel fermenters (F3 and F6 in Figure 1.1) that are combined together 
before downstream processing.   For the fluorescence analysis, a total of four samples were collected 
for each upstream fermentation step (F3-S, F6-S, CPS-B2-(F3), CPS-B2-(F6)) corresponding to 
samples from each fermenter and their corresponding centrifuged samples. Samples were collected 
twice per week since fermentations are conducted every 3.5 days. Thus a total of 8 samples were 
collected every week.  
As shown in the process flow diagram (Figure 1.1), CPS-B2-(F3) and CPS-B2-(F6) samples are 
combined and filtered. The two resulting batches of broth are combined together and sent to the 
downstream purification process. From the ultrafiltration step, there are four samples (two for CPS-
Conc and two for CPS-Conc-PW (permeate waste)). From the perlite chromatography column, four 




1.1). After the first ammonium sulphate precipitation (two SKA-S1 samples and two SKA-P1-R 
samples), the two pellets (SKA-P1-R) are combined and precipitated again with ammonium sulphate 
at 10% w/v. After the third ammonium sulphate precipitation at 20% w/v, the samples analyzed are: 
SKA-S3, SKA-P4, SKA-CH1, UF/D1, SKA-UF/D2, SKA-CH2. In total, 25 samples for each batch 
were analyzed as summarized in Table 3.1. 
Step Step ID Number of Samples 




CPS-B2 (F3) 2 













Chromatography Column SKA-CH1 1 
First Ultrafiltration/Diafiltration UF/D1 1 
Second Ultrafiltration/Diafiltration SKA-UF/D2 1 
Chromatography Column SKA-CH2 1 
Total 25 
 




















Seven different batches were analyzed: A, B, C, D, E, F, G (Table 3.2). These samples were initially 
stored in a freezer at -20ºC. After thawing, all samples were diluted prior to fluorescence analysis. 
The upstream fermentation samples (CPS-Conc, CPS-Conc-PW), were diluted with 0.9% saline 



































buffer (0.15 mM NaCl). SPEP-R-Conc and SPEP-R-Conc-PW were diluted with 50 mM Tris-HCl 
buffer, and the rest of the samples with 10 mM Tris-HCl buffer. Tris-HCl buffer was prepared with 
Trizma base (Tris-(hydroxymethyl)-aminomethane) with pH adjusted to 8.0 using HCl. The dilution 
factor was 0.05.   
Table 3.2 shows final Kjeldahl values for each batch in the last step of the PRN purification (SKA-F). 
The “PRN batch start year” is the year when the batch was obtained. The “Pass-thru” are samples 




































Table 3.2 Kjeldahl values per batch 
 
The Kjeldahl method is a procedure for quantitative determination of proteins based on the nitrogen 
content present in a sample. This method is composed of three main steps: digestion, distillation and 




excess of concentrated sulfuric acid solution. In this manner, the organic nitrogen is converted to 
ammonium salt. The digestion ends when the sample, initially dark-colored, becomes clear and 
colorless. The sample is then distilled with an excess of a concentrated sodium hydroxide solution, 
which converts the ammonium salt into ammonia. The latter is condensed and reacted with an excess 
of boric acid. As a result, ammonium borate is formed. The last step consists of the titration of the 
ammonium borate with hydrochloric acid. The concentration of hydrogen ions determined in this step 
equals the concentration of nitrogen in the sample. 
The Kjeldahl analysis used to determine the values shown in Table 3.2, were conducted at Sanofi.  
3.1.2 Acquisition of Fluorescence Spectra 
Fluorescence excitation-emission spectra were acquired with a Cary Eclipse Fluorescence 
Spectrophotometer from Agilent Technologies. The samples were analyzed using quartz cuvettes 
using a slit width of 5 nm and PMT of 600 V. These parameters were chosen based on the spectra 
acquired from samples at different dilutions and at different values of slit widths and PMT. Good 
signal, reproducibility, inexistence of quenching due to concentration were the aspects taken into 
account for selecting those parameters. The excitation and emission ranges were 210-470 nm and 
260-550 nm respectively. A wide range of Ex/Em values was used to ensure that all fluorophores 
were captured.    
3.1.3 PCA and PLS Analysis 
The fluorescence spectra acquired for each sample consisted of 8148 intensities obtained for different 
excitation/emission combinations (28 x 291 data matrix). The intensity values for each sample were 




one sample. The rows were stacked together as described in Figure 3.3 to generate one data matrix for 
PCA and PLS analysis.  
 
 
Figure 3.2 Steps involved in generating data rows of intensity values for PCA (adopted with 
modifications from Peiris, 2010) 
 
To identify whether the variability in productivity originates from a specific step or a combination of 
steps  of the manufacturing process, four main data matrices were generated as follows: (i)- Upstream 












Principal Component Analysis (PCA) 
Step 1: Rearrangement of 
intensity values to a row 
Step 2: Construction of a data matrix (X) with 
intensity values rearranged for each sample 
Each column is transposed 




Downstream 1 (with samples from SPEP-R-Conc, SPEP-R-Conc-PW, SKA-S1, SKA-P1-R, SKA-S3, 
SKA-P4, SKA-CH1, UF/D1, SKA-UF/D2, SKA-CH2), (iii)- Downstream 2 (with samples from 
SPEP-R-Conc, SKA-P1-R, SKA-P4, SKA-CH1, UF/D1, SKA-UF/D2, SKA-CH2) and (iv)- 
Downstream 3 (with samples from SPEP-R-Conc-PW, SKA-S1, SKA-S3). Downstream 1 matrix, 
which contains all the spectra obtained from samples in the downstream, was separated into two 
matrices: Downstream 2, which excludes waste samples, and Downstream 3 which includes waste 
samples. 
Even though CPS-Conc and CPS-Conc-PW belong to the downstream process as per the company 
classification, they were considered together with samples from the upstream data matrix for PCA.  
They were considered together since up to the centrifugation step, from which CPS samples are 
obtained, there is a significant amount of antigens and co-enzymes in the samples.  Thus, it was 
expected that by tracking samples where proteins are abundant, higher sensitivity to variability in 
fermentations outcomes may be obtained. 
 
The four data matrices defined above were analyzed using principal component analysis (PCA). PCA 
is a multivariate statistical method that reduces the original variables into a lower number of 
orthogonal (non-correlated) principal variables referred to as principal components (PC) (Wise et al., 
2006). These PC’s are linear combinations of the original variables (fluorescence intensities) that 
capture the variability in the data. Only a subset of the PC’s that describe a significant percentage of 
the variability is kept for further analysis whereas the remaining PC’s are discarded on the assumption 
that they correspond to noise.  
PCA decomposes a set of data (matrix X) as the sum of the products of vectors si and pi, plus a 




 = ∑  ∗  +                                                             (3.1) 
Where n is the number of samples. The si vectors are known as scores and contain information on 
how the samples relate to the principal components. The pi vectors are known as loadings and contain 
information on how the original variables relate to each other along the principal components.    
Before doing this multivariate analysis, it is necessary to pre-treat the data by performing mean 
centering and scaling. By performing mean centering, the average is subtracted from every column, 
so the new mean of each column is zero. The data is scaled to have unit variance by dividing each 
column by the standard deviation of the values in that particular column. Without normalization by 
the variance, the PCA model could wrongly focus on few variables with the largest absolute variances 
(Wise et al., 2006)   
To choose the number of components to be kept for further analysis cross-validation was done with 
the random subset method (Wise et al., 2006). This method consists of dividing the data into a 
number of subsets (N) randomly selected. Then, the model is built based on N-1 subsets, leaving one 
out. The model is then used to predict the subset left out. The resulting prediction error is then plotted 
against the number of principal components (PC’s), and the number with less error is chosen. 
Generally, the error is presented as the Root Mean Square Error of Cross-Validation (RMSECV), 
which is defined as: 
"#$% = &∑ (()*(+, )./)01                                                            (3.2) 
Where 2 is the measured value, 23 is the predicted variable and n is the number of calibration 




While PCA performs data compression on the input data only, i.e. fluorescence intensities, other 
multivariate statistical methods are needed to correlate the input data to other measured data. Partial 
Least Squares (PLS) is a multivariate regression method that correlates the information in one data 
matrix (X) to the information in another matrix (Y). PLS is used to obtain a regression model between 
X to Y so that newly acquired values of X could be used to predict Y.  
In this project, PLS was used to obtain a regression model between matrix X, corresponding to the 
fluorescence spectra of pure PRN corresponding to samples of SKA-CH2 (see Fig. 1.1) , and matrix 
Y corresponding to the final protein content measured by a Kjeldahl test. PLS also requires 
autoscaling and cross-validation as explained above for the PCA procedure.  
PLS performs data compression and extracts a small number of latent (not directly measured) 
variables (LVs) that describes the observed or measured data. In contrast to PCA, PLS not only finds 
the major variations in X and Y, but identifies the latent variables that correlate the scores in the X 
matrix with the scores in the Y matrix to have maximum covariance. 
In this sense, PLS decomposes X and Y matrix as follows: 
 =  +  = ∑  ∗  +                                                      (3.3) 
 =  +  = ∑  ∗   +                                                      (3.4) 
Where m is the number of latent variables. The ti and ui vectors are the scores and contain 
information on how the samples relate to the latent variables. Scores in T are the projections of the 
input data X, i.e. fluorescence intensities to a LV in the X-space, and scores in U are the projections 




loadings and represent the relationship between T and X-space, and U and Y-space respectively. E 
and F contain the variables left unexplained by the model.  
The inner relation between U and T is given by the following equation  
 = !                                                                  (3.5) 
Where W is the weight matrix. From equation 3.5, it is possible to predict the scores in Y from scores 
in X, and then the new response data from equation 3.4. 
To predict the response (Yp) from a new set of data (Xnew), the T score matrix can be calculated by 
multiplying Xnew by the known loadings (Q) from the calibration model. Subsequently, U can be 
calculated using Equation 3.5. The new response (Yp) is then calculated by multiplying U by the 
known loading value C (Equation 3.4).  
Another way to obtain the new Y response is by multiplying the known values Q, C and W from the 
calibration model to obtain one matrix (B) called the regression coefficient matrix. In this manner, Y 
can be predicted by multiplying the new data (Xnew) by matrix B:    
 = K                                                                  (3.6) 
In this project, PCA and PLS analysis were performed using the PLS_ Matlab Toolbox (Eigenvector 
Research Inc., Manson,WA). Data collection, analysis and plotting were conducted using MATLAB 





3.2 Enzyme assay 
3.2.1 Materials 
The following substrates were obtained from Sigma-Aldrich Co. LLC.: β-nicotinamide adenine 
dinucleotide, reduced dipotassium salt, sodium pyruvate solution, maleate standard for IC, 
oxaloacetic acid, α-ketoglutaric acid, iodonitrotetrazolium chloride, CB 1954  or 5-(1-Aziridinyl)-2,4-
dinitrobenzamide (substrate for ubiquinone oxidoreductase) . The analyzed samples were provided by 
Sanofi Pasteur (Toronto, Ontario, Canada) CPS-Conc-PW from batch A (Table 3.2). 
The samples were diluted in 0.9% saline buffer (0.15 mM NaCl). A stock solution for each substrate 
(4 µM) was prepared. The dilution factor for the sample was 0.05. The samples were spiked with the 
substrates using three different dilution factors: 0.007, 0.013, and 0.033.  
3.2.2 Fluorescence Spectra 
Fluorescence excitation-emission spectra were acquired with a Cary Eclipse Fluorescence 
Spectrophotometer from Agilent Technologies. The samples were analyzed in quartz cuvettes. A Slit 
width of 5 nm and PMT of 600 V were used. The excitation and emission ranges were 210-470 nm 
and 260-550 nm, respectively. These wide ranges were taken in order to cover the Ex/Em values for 




3.3 Assessment of the effect of temperature on fluorescence 
3.3.1 Materials 
SPER-R-Conc samples from batches A3 and A4, CPS-B2-(F3) samples from batches G1 and G2, and 
a F3 sample from batch J were provided by Sanofi. 0.9% saline buffer (0.15 mM NaCl) was 
employed for the dilution of the samples. The dilution factor was 0.05. 
3.3.2 Temperature Assessment and Fluorescence Measurements 
In the first assessment, SPEP-R-Conc samples were left at -30ºC for 24 hrs, and then brought to 20ºC 
by rapid thawing. Another sample was left at 20ºC for 24 hrs and a third sample was heated at 90ºC 
for 1 min. Fluorescence spectra were acquired in the three cases. In the second assay, fluorescence 
spectra for CPS-B2-(F3) samples were measured after cooling at 4ºC and raising the temperature to 
25ºC, repeatedly for three days. In the third assay, a F3 sample was subjected to changes of 5ºC for 
three times (25ºC, 30ºC, 35ºC). Fluorescence spectra were measured in each case. In all cases, the 
fluorescence signals were acquired as explained in section 3.2.2. 
3.4 Centrifugation of Samples 
3.4.1 Materials 
F3 and F6 samples from batches G1 and G2 were provided by Sanofi. 0.9% saline buffer (0.15 mM 




3.4.2 Centrifugation and Fluorescence Measurements 
The samples were centrifuged for 5 min at 23,000 xg. Fluorescence spectra were acquired before and 
after centrifugation as explained in section 3.2.2. 
3.5 Surface phosphophilicity assay 
3.5.1 Materials 
The following adsorbed samples onto aluminum phosphate adjuvant were provided by Sanofi Pasteur 
(Toronto, Ontario, Canada): pertactin (PRN) from batch K (February 15, 2011), difteria toxin (DCA) 
from batch L (September 12, 2011), tetanus toxin (TCA) from batch M (August 30, 2011). 
In the process of adsorption, aluminum phosphate solution is added to the antigens, and then stirred 
for 4 days, at 16ºC to 24ºC.      
Two types of buffer were used: 0.9% saline buffer (0.15 mM NaCl), and PBS (phosphate buffered 
saline). 
Fluorinated fluorogenic substrate 6,8-difluoro-4-methylumbelliferyl phosphate  was purchased from 
Molecular Probes, Inc. Dimethyl sulfoxide DMSO and MOPS buffer were purchased from VWR 
International LLC.    
A 10 mM DiFMUP stock solution was made by dissolving the entire content of the vial (5 mg) in 
1.71 mL of DMSO (dimethyl sulfoxide). From this solution, a 500 mM DiFMUP solution in 100 mM 




3.5.2 Fluorescence Spectra 
A Synergy 4 Multidetection Microplate Reader from Biotek Instruments, Inc was used to read 
fluorescence intensities.  
Five wells in the microplate were used and filled as follows:  
- Well A: 100 µL saline buffer – 20 µL DiFMUP 
- Well B: 100 µL PBS – 20 µL DiFMUP 
- Well C: 100 µL PRN – 20 µL DiFMUP 
- Well D: 100 µL DCA – 20 µL DiFMUP 
- Well E: 100 µL TCA – 20 µL DiFMUP 
 The excitation and emission wavelengths were 358 nm and 450 nm, respectively, corresponding to 
the characteristic fluorescence values for 6,8-difluoro-4-methylumbelliferone (DiFMU), resulting 










Chapter 4  
Results and Discussion 
Proteins consist of one or more chains of amino acid residues. Some amino acids, such as tryptophan, 
tyrosine and phenylalanine are intrinsically fluorescent. Tryptophan is the most useful in fluorescence 
analysis since, due to its high quantum yield and high sensitivity to its local environment, can be used 
for inferring conformational transitions, protein-protein interactions and/or denaturation (Royer et al., 
2006; Lakowicz et al., 2007).  Enzymes cofactors, such as NAD(P)H and FAD, are usually 
fluorescent. Since their quantum yields change upon binding to proteins, fluorescence from these two 
fluorophores has been extensively used to study their interaction with enzymes (Lakowicz et al., 
2007).  
To monitor the PRN manufacturing process, reproducible fluorescence spectra were obtained in order 
to track changes of the aforementioned fluorophores that could elucidate possible causes of variability 
in the final product yield.  
4.1 Fluorescence Analysis 
The main information contained in typical fluorescence EEMs measured for samples analyzed for 
each batch (Table 3.1) are qualitatively interpreted in this section.  Explanations are given for the 
spectra obtained at different intermediate steps of the manufacturing process to elucidate possible 
sources of process variability and correlations of the observations with the protein concentration 
measured and collected at the end of the manufacturing process. The different steps of the 




In general, the spectra for all samples analyzed exhibited two peaks (α, α’) related to tryptophan 
(Trp) at excitation wavelengths of (Ex) 230 nm and 280 nm, and emission wavelengths (Em) from 
330 nm to 350 nm. The wavelengths at which tryptophan exhibits significant emission intensities 
depend on the location of the amino acid residue in the protein. When the Trp residues are buried in 
non-polar regions of the protein, a blue-shift is observed. As the residues are located closer to the 
surface and more exposed to the environment, the emission intensities occur at higher wavelengths 
(red-shift) (Burstein et al., 1973). Emissions for free tryptophan in solution are observed around 350-
360 nm. Excitation of Trp at 230 nm is caused by absorbance of its carboxylic moiety and excitation 
at 280 nm is the result of absorbance by the indole ring. Another two peaks (β, β’) associated with 
NAD(P)H at excitations 280 nm and 340 nm, and emission 460 nm are observed in the measured 
spectra. Typical excitations wavelengths for NAD(P)H are occurring at 260 nm and 340-360 nm, 
corresponding to the absorption by the adenine and pyridine rings, respectively (Rover et al., 1998). 
Binding of NAD(P)H to other proteins can cause a shift in its excitation wavelength from 260 nm to 
280 nm. This shift is observed in the spectra obtained from early steps in the manufacturing process, 
and it is believed to be due to the binding of NAD(P)H to a dehydrogenase (Gazzotti et al., 1974;  
Lakowicz et al., 2007).  
In the fluorescence spectrum for component pertussis (CP) broth, a peak (γ) attributed to amino acids 
appears at Ex/Em~330/410 nm, and strong peaks (δ, δ’) at Ex/Em~230-275/310 appear as the 







Figure 4.1 EEMs for CP broth (concentrated and diluted). 
 
There are two spectra (Fig. 4.1) for the same broth, but one for concentrated broth and the other for 
diluted (the dilution factor was 0.05). In the spectrum for concentrate broth, the tyrosine peak at 
Ex~275 nm is stronger than the peak at Ex~230 nm, even though the coefficient of absorption (ε) is 
higher at lower wavelengths (ε~9000 M-1 cm-1 at Ex~220 nm and ε~1400 M-1 cm-1 at Ex~275 nm in 
water) (Creed, 1983). This is likely due to energy transfer that occurs at higher concentrations 
between molecules resulting in higher emission at Ex~275 nm. On the other hand, in the spectra 
shown for the diluted broth, the tyrosine peak at Ex~230 nm appears with higher intensity. In this 
case, energy transfer is not efficient since the sample is diluted and contact between molecules is 
reduced.   These differences in the emission also can be observed for tryptophan which shows a 















First order Rayleigh scattering (FORS) and second order Rayleigh scattering (SORS) can be 
indicative of protein aggregation. Raman scattering (RS) emerges from the interaction of light with 
solvent molecules, and it is noticeable at low concentrations of fluorophores (Deshpande, 2001).       
Similar patterns have been observed in the spectra among the seven batches analyzed in this work, but 
there are differences among steps and among batches with different final protein content as 
determined by Kjeldahl analysis. Such differences are observed in the emissions wavelengths, in the 
intensities at a particular excitation wavelengths and shifts in significant excitation wavelengths. The 
latter shifts are for example related to the fact that tryptophan can emit at an excitation wavelength of 
230 nm and 280 nm (peaks for both excitations are observed in all steps). For native PRN, emission 
of tryptophan arises at 335 nm, but when in solution it occurs at 350 nm (Junker et al., 2006). 
For the upstream fermentation steps (F3-S, F6-S, CPS-B2-(F3), CPS-B2-(F6)), the intensities were 
relatively low despite the expected abundance of proteins in the samples, since at this point of the 
manufacturing process all antigens are present. The low fluorescence intensity is believed to be due to 
quenching resulting from the presence of suspended particles. A shift in the emission of Trp to ~340 
nm is observed suggesting that Trp residues may be exposed on the surface due to unfolding of the 
protein (α,α’). Figure 4.2 show the spectra obtained for fermenters F3-S and F6-S, and Figure 4.3 





























































































As stated before, an excitation shift from 260 nm to 280 nm for NAD(P)H is observed in the spectra 
(β’), suggesting a binding with a dehydrogenase. The typical emission of this cofactor at excitation 
340 nm is also observed (β). A small shoulder around Ex/Em 330/410 nm (γ) also appears possibly 
due to the emission by amino acids in the media.  
Another peak (φ) generally associated to FAD occurs as a shoulder at Ex/Em=450/530 nm. FAD is a 
product of the TCA cycle for which activity is expected to be significant for aerobic fermentations. At 
this point, it is not possible to determine with fluorescence whether the emissions originate solely 
from tryptophan contained in PRN since PT, FHA, FIM among other proteins are also present in the 
samples. Since FIM does not contain tryptophan so fluorescence from this protein would originate 
mainly from tyrosine (Crowley-Luke et al., 2001). 
In the fluorescence spectra of CPS-Conc samples, a shift in the emission of Trp is still observed (α) 
while emissions for the remaining fluorophores appear without a significant variation. On the other 
hand, in the EEM for the permeate waste (CPS-Conc-PW), a prominent emission for NAD(P)H-
dehydrogenase complex is observed. This peak appears with higher intensity in batches where the 
final protein content for PRN, measured by Kjeldahl, is low thus possibly suggesting a correlation 
between the abundance of this complex in the samples collected from the fermentations and the final 



















































After the perlite column, samples from the ultrafiltration, SPEP-R-Conc and SPEP-R-Conc-PW, 
show the following spectra: 
 
Figure 4.5 EEMs for SPEP-R-Conc and SPEP-R-Conc-PW for batch A. 
 
In the SPEP-R-Conc EEM, the emission peaks for fluorophores other than tryptophan start to become 
less evident . On the other hand, fluorescence signals corresponding to NAD(P)H, FAD and 




































proceeds, the peak of Trp becomes more intense possibly correlating with the expected progressive 
increase in concentration of the protein in the sample. 
For EEM of the sample referred to as SKA-R-P1, the most intense peak as expected is the one 
corresponding to tryptophan since the sample contains mostly protein. At this point, the two parallel 
manufacturing lines of the process are combined together to obtain a higher concentration of protein, 
as compared to the protein levels observed in samples prior to being combined.  In contrast, lower 
intensities of Trp are observed for the SKA-S1 waste indicating a relatively small loss of protein from 
the system. The Trp could be related to the presence of other antigens and to some wasted PRN. Also, 











































A large Trp peak is present in the supernatant waste originating from the third ammonium sulphate 
precipitation (SKA-S3). The Em at ~340 nm suggests that the Trp residues may be exposed to the 
solvent due to unfolding, but it is not possible to ascertain whether this emission comes from PRN 
since other antigens could still be present in the sample. For the resulting pellet from this step (SKA-
P4), only the Trp peak is present, and the dominant emission wavelength starts to resemble the 
characteristic value for PRN at 335 nm as reported in literature (Junker et al., 2006).   
 
 
























































From this point on in the process until the last step (SKA-CH2 sample), only the Trp peak is observed 
in the EEM. There is a decrease in the intensities which may be a result of the elimination of traces of 
other antigens during the later stages of the purification.    
4.2 PCA Analysis 
As described in Section 3.2.3, four data matrices associated with different sections of the 
manufacturing process were analyzed using PCA in order to obtain fewer variables to describe major 
correlations in the original data. After performing cross-validation, and calculating the RMSECV, the 
number of components and the variance captured for each data matrix was obtained and is presented 
in Table 4.1.   
 






















1 52.55 52.55 80.17 80.17 80.98 80.98 80.77 80.77 
2 23.85 76.39 14.12 94.29 15.75 96.73 13.11 93.88 
3 12.69 89.09 - - - - - - 
 
Table 4.1 Variance captured by each principal component in upstream and downstream samples. 
 
For the four data sets, the cumulative variance captured for the PC’s was approximately 93% and the 
percentage leftover, is related to unaccounted effects and noise. 
The variance and the cumulative variance for a data set containing samples from the whole process 




 All Data (Upstream and Downstream) 
PC Variance % Cumulative Variance % 
1 75.99 75.99 
2 12.49 88.48 
3 5.85 94.33 
 
Table 4.2 Variance captured by each principal component in samples from the whole process 
 
The meaning of each PC is given by the loadings, which represent the relationship between the 
original space and the new space. In this case, the loadings could be seen as the representation of the 
most important excitation/emission wavelength combinations in terms of the amount of variability 
described by these combinations (Persson et al., 2001). The fluorophores with the highest intensities 
in the original matrix X would be generally correlated to the highest intensities for the corresponding 
peak in the loading matrix.  
 
Loading plots for PC1, PC2 and PC3 data matrix containing the spectra from samples of the entire 













For PC1, the scattering peaks (FORS) and Trp (α, α’) present the highest intensities, and for this 
reason, it is assumed that this component is primarily correlated with the protein content. The 
negative values indicate that there is an inverse correlation: when protein content is high, the score 
values are negative. On the other hand, the loadings for PC2 show a peak in the region where the 
emission of Trp is characteristic (α, α’) so It is also assumed that PC2 is related to protein. Unlike in 
PC1, the loadings for PC2 are positive, meaning that there is a direct proportional correlation.  For 
PC3, the loading plot presents higher positive intensities for the peak related to NAD(P)H-enzyme 
complex (β’), indicating a direct correlation with this fluorophore. 
To identify possible differences between the upstream and downstream phases, the loadings from the 
spectra measured for the upstream and downstream samples were individually calculated. The 
loadings for the first 3 principal components PC1, PC2 and PC3 for the upstream data matrix are 






















In the loading plot for PC1, the intensities with higher values are those corresponding to Trp (α, α’) 
and scattering (FORS).  Because intensity is large for what is attributed toTrp, it is hypothesized that 
PC1 is most likely related to protein. Since the actual values of the loading vector are negative, there 
is an inverse correlation: when the score value is negative, protein content is high, and vice versa. It 
should be noticed that although the fluorescence intensities are positive, negative PCA scores occur 
because of the mean centering and scaling procedure applied to the data before building the PCA 
model. On the other hand, the loading plot for PC2 possesses higher negative intensities for the peak 
attributed to the NAD(P)H-enzyme complex (β’), indicating an inverse correlation with this 
fluorophore.  For PC3, the EEM shows a shoulder with positive intensity values where Trp emission 
is characteristic (α, α’), but the maximum emission presents a red-shift. This could be indicative of 
conformational changes in the proteins, since when tryptophan is more exposed to the environment, 
the emission is shifted to higher wavelength (Burstein et al., 1973; Junker et al., 2006; Seabrook et 
al., 1991). 
For the three data matrices constructed from samples collected from steps further downstream, the 
loading plots related to PC1 and PC2 show an inverse correlation to scattering (FORS) and a 
proportional correlation to protein content, respectively. Loading plots for these principal components 


























Figure 4.11 PC1 and PC2 loadings for downstream 1. 














Comparing the loadings calculated for the downstream samples with those calculated for the upstream 
samples, the NAD(P)H-enzyme binding peak is not significant or is not present at all in the 
downstream loadings. When comparing the loadings from the PC’s of the entire process to the 
loadings from the upstream and the downstream steps, the most appreciable difference is the NADH-
enzyme complex peak.  In the analysis of the data set containing all samples, PC3 which is dominated 
by the NADH-enzyme complex fluorescence, captures only 5.85% of the variance in the data. 
However, in the data set with samples from the upstream step, the variance captured by PC2, which is 
dominated by the NADH-enzyme complex for the upstream samples, is 23.85%. This suggests that 
FORS 
α 




this NADH-enzyme complex only has a significant influence in the variability of the process related 
to the upstream steps, and not to the entire process.    
The relationship among different samples can be extracted from the score plots (Wise et al., 2007). 
By comparing the score of each sample for each principal component, similarities and differences can 
be estimated among the original samples (Persson et al., 2001).  
Score plots for the data matrix of the whole process are shown in Figures 4.14 and 4.15, and the score 



































Each point in the score plots represents the score for a particular sample. The lines between scores 
correspond to samples for a particular batch to allow for easier visualization of the correlation between 
fluorescence and productivity according to batch. The batches that resulted in low or high final Kjeldahl 
values (as indicated in Table 3.1) are denoted by an L or H, respectively next to the sample number. For 
easy visualization, the batches with low final Kjeldahl (L) values are shown with blue lines in all the 
score plots.  
As previously discussed, for the upstream data PC1 and PC2 are inversely correlated to protein content 
and NAD(P)H-enzyme complex concentration respectively, and PC3 in directly correlated to protein 
content. The main objective of this analysis was to find a possible correlation between the fluorescence 
corresponding to different steps of the production process and the final PRN concentration in the final 
stage of the purification in order to identify possible causes of low productivity for this product. 
For the PC1-PC2 score plot, the batches with low final Kjeldahl (Table 3.1) have the largest negative 
values for PC2, indicating that the quantity of NAD(P)H-enzyme complex in the samples is higher in the 
batches with low final Kjeldahl as compared to those lots with high final Kjeldahl. Also most of the score 
points for the batches with low productivity have positive values for PC1. The fact that there is a high 
NAD(P)H-enzyme complex concentration and low protein content for these batches hint at the possibility 
that some metabolic steps related to the consumption of NADH are proceeding at different rates in 
different fermentations and these differences maybe a source of variability in the final yield of PRN.  
During oxidative phosphorylation, co-enzymes such as NADH and FADH2 act as electron donors, and O2 
as acceptor resulting in ATP formation. In the absence of oxygen or in cases where there may be oxygen 
transfer limitations, NADH cannot be oxidized sufficiently fast and therefore it may accumulate (Marose 




Some score points for batches with high productivity also fall in the low protein content area of the plot. 
This suggests that for these batches, not all the four fermentations proceeded to completion.   

































From these plots, it is not possible to identify any pattern that differentiates batches with low final 
Kjeldahl from batches with high final Kjeldahl. Thus, samples that belong either to batches with high 
Kjeldahl or low Kjeldahl are dispersed in the plots thus exhibiting a lack of correlation between scores 
and productivity.  For this reason, downstream purification protocols were dismissed as a cause of low 
productivity. 
4.3 Investigation of the correlation between productivity and dissolved oxygen, aeration 
and agitation profiles recorded during the fermentation. 
With the observation that NADH accumulates in different amounts for different runs and that this 
accumulation maybe related to oxygen transfer limitations, dissolved oxygen and aeration rates were 
investigated. These parameters are recorded on-line during the fermentations and the results are stored in 
a database. 
Dissolved oxygen profiles for each batch are provided in Figure 4.21.  
No significant differences between the profiles of dissolved oxygen for fermentations that produced 
higher or lower levels of pertactin were observed.  Thus, there seems to be no appreciable relationship 
between dissolved oxygen levels in the fermenters and the variability observed following the downstream 
processing. It should be noted that dissolved oxygen is controlled in closed loop during the fermentation 
by manipulating the aeration rate. Thus, the dissolved oxygen is generally fairly constant at its set point 






Figure 4.21 Dissolved oxygen in fermenters F3 and F6. Batches with high final Kjeldahl are marked with 




An additional possible indicator of changes to oxygen rates is the aeration rate time profile since the 
aeration rate is manipulated to control the dissolved oxygen at a preset set point value.  In the airflow 
profiles, there are some differences among batches, but the relationship between the aeration levels and 
variability in protein concentration is not straightforward. Since the final protein concentration was found 
to be negatively correlated to the scores of PC1 and PC2, the aerations rates were compared in different 
batches to these scores. For example, in a high productivity batch D2 (green line in Figure 4.16), the 
airflow in the first fermenter F3 was low compared to the other batches, while the scores for this sample 
(Figure 4.16) were positive for PC1, implying low protein content, and negative for PC2 implying high 
NAD(P)H content. The airflow in the second fermenter F6 for this batch was high, and the scores were 
positive for PC1, as in F3, but positive for PC2 thus implying a low NAD(P)H content.  Comparing to a 
batch with low productivity, such as A2 (dark blue line in Figure 4.16), the F3 airflow was higher than for 














Figure 4.22 Airflow in fermenters F3 and F6. Batches with high final Kjeldahl are marked with solid 





Figure 4.23 Agitation in fermenters F3 and F6. Batches with high final Kjeldahl are marked with solid 




Similar to the dissolved oxygen profiles, there is an overlap among agitation profiles belonging to batches 
with high and low productivity, showing no clear correlation between this parameter and variability in the 
final protein content.  Agitation rates are shown in Figure 4.23. In these profiles, there is an apparent 
relationship between agitation rate and productivity but this is not consistent. For instance, in batches C1, 
C2 and B2, which had low productivity, agitation ramped slowly from the minimum to the maximum rpm 
value required to maintain the dissolved oxygen set point.  However, in F3 for batch D2, the agitation 
ramped slowly compared to F6 for the same batch, even though the final batch for this fermenter had high 
productivity. The PC2 score for F3-S D2 in Figure 4.16 has a negative value suggesting high NAD(P)H 
content which corresponds to lower oxygen  consumption and a corresponding slower ramp in aeration 
needed to maintain the desired oxygen set point as observed. Thus, the fluorescence scores appear to be 
more correlated to productivity than agitation rate. 
It should be noted that to calculate the actual consumption of oxygen by the cells it would be necessary to 
measure, in addition to dissolved oxygen and aeration rates, the oxygen leaving the fermenters, which is 
not possible with the current set-up. Thus, measuring the NADH using fluorescence offers an advantage 
for identifying differences in metabolism, in particular as related to oxygen consumption.  
4.4 Investigation of supplementation time as indicator of productivity 
An attempt was made to correlate the variability in productivity to the start time for fed-batch 
supplementation. For example, it was observed that the supplementation time, i.e. the time at which fed-
batch operation is started, varies among the different runs. The supplementation times as obtained from 
Figure 4.23 which show the change in the level of the supplementation tank from the beginning of the 
fermentation. During the first period that corresponds to batch operation and no supplement is fed to the 
fermenter, the level in the supplementation tank is constant at its initial value. Thus, the supplementation 
time corresponds to the instant at which the level in the supplementation tank starts to decrease (Figure 




the standard current operating procedure it is assumed that a sudden increase in dissolved oxygen 
correlates with the complete consumption of glutamine thus necessitating supplementation. Comparing 
the time at which the spike in dissolved oxygen occurred and the supplementation time, there are not 
significant differences and the supplement was added at the moment when the spike appeared. On the 
other hand, it is seen from Figure 4.23 that some batches that had low productivity (C1, C2 and B2) 
exhibit relatively late supplementation time (~30 hrs) compared to other batches (~25 hrs), suggesting that 
the supplementation time may be correlated to the final product yield. However, this is not consistent for 
all batches since there are batches with low supplementation time that resulted in low pertactin 
productivity. It should be pointed out that although the need for supplementation is established, as 
explained above using dissolved oxygen measurements, the start of supplementation is manual. Thus for 
the actual process the supplementation may not be implemented exactly after the observed increase in DO 







































Figure 4.24 Supplement Quantity in fermenters F3 and F6. Batches with high final Kjeldahl are marked 




4.5 Investigation of key metabolites’ levels   
Besides the parameters monitored during the process, key components of cell metabolism, such as lactate, 
glutamate and glutamine, were also monitored. It was hypothesized that changes in NADH will be 
associated to changes in the consumption or production of key metabolites.   Figures 4.25, 4.26 and 4.27 
show the measured concentrations for lactate, glutamine and glutamate for different batches conducted in 
fermenters F3 and F6 as a function of the corresponding final Kjeldahl pertactin concentration. The 
samples were obtained at the end of the fermentations.  
 














For lactate and glucose, there are not pronounced differences among the batches with high and low 
productivity. However, for the glutamine profile, there are some batches with low final Kjeldahl that 
show high concentration of this metabolite respect to the others. This could reinforce the hypothesis that 
low pertactin productivity is associated with oxygen consumption.. Following such limitations glutamine 
consumption may be lower as compared to fermentations where such limitations do not occur. It should 
be noted that the analysis performed here was conducted at the end of the fermentation. A more detailed 
assessment of metabolic changes would require measuring metabolite levels during the course of the 
fermentation process. This would be a very challenging task since such measurements cannot be done 
currently on-line. 
4.6 Simple growth model to explain the observed variability 
A possible explanation to the variability observed in the fermenters can be proposed based on a simplistic 
model of the fermentation process. The biomass and substrate mass balances in batch are given as 
follows: 
LM
LN = OP                                                                        (4.1) 
LQ
LN = RSP                                                                      (4.2) 
where P is the biomass concentration, O is the growth rate constant, S is the substrate concentration and R 
is a kinetic constant. A graphical solution of these equations for two different initial biomass 





Figure 4.28 A: Biomass concentration vs. time; B: Substrate concentration vs. time. 
 
Based on these profiles, it can be observed that the smaller the inoculum (small xo), the start of the 
supplementation time will occur later as observed in the process.  Also, slower consumption of glutamine 
for a smaller initial biomass concentration will explain the observed lower aeration and stirring speed 
rates observed for the different runs. Thus, variability in the inoculums could explain some of the 
observed operational differences.  In general, it was observed that low productivity was associated with 
slower oxygen consumption rates and later supplementation times. Lower oxygen consumption may 
explain the higher levels of NADH observed by fluorescence. Also, such lower consumption would be 
correlated to lower levels of ATP with resulting lower productivity. However, these correlations were not 





4.7 Regression models between PCA scores obtained from fermentation samples and 
pertactin productivity 
This section describes the formulation of a regression model among the averages of PC1 scores and PC2 
scores obtained for samples collected from the fermenters, and final Kjeldahl values. This model was 
done for assessing whether there is a statistically significant correlation between fluorescence fingerprints 
in the fermenters and final pertactin productivity (Figure 4.29). 
 
 











The resulting equation is: 
T(P, 2) = U − V ∙ P +  ∙ 2                                                       (4.3) 
R2: 0.8753 
Where: 
U = 4.2  (3.592, 4.808) 
V = 0.1393  (0.06899, 0.2095) 
  = 0.02326  (0.001802, 0.04472) 
(Coefficients with 95% confidence bounds) 
P = Average of PC1 Scores (protein content in the fermenters) 
2 = Average of PC2 Scores (NAD(P)H-enzyme content in the fermenters) 
T(P, 2) = Protein content measured by Kjeldahl (PRN in the final purification step) 
From the regression model, one can conclude that when the protein content is high, P (average of PC1 
scores) is negative, therefore T(P, 2) increases. On the other hand, when NAD(P)H content is high, 2 
(average of PC2 scores) is negative, therefore T(P, 2) decreases.  
The coefficient V was chosen to be squared to avoid zero as a possible value. When V is not squared in 
Equation 4.3, the 95% confident bounds for this coefficient are -0.03896 and 0.0001768, allowing zero as 
a possible value, which would mean that in some cases the protein content measured (T(P, 2)) can be 
independent of P, i.e. protein content in fermenters, which is not valid. 
A PLS model was also built using the average for PC2 scores related to NADH complex and Kjeldahl 
values. First, the regression was performed using the average of the scores for seven batches, resulting in 





Figure 4.30  PLS regression between PC2 scores (NADH complex) and Kjeldahl values for 7 samples. 
 
Since the model did not fit the data properly, a second model was constructed with six batches 





Figure 4.31 PLS regression between PC2 scores (NADH complex) and Kjeldahl values for 6 samples. 
 
4.8 PLS based regression for predicting pertactin 
An additional regression model was developed using Partial Least Square (PLS) for predicting the final 
pertactin concentration based on fluorescence measurements obtained from samples collected in the final 
step of the purification process. The objective was to see whether fluorescence can be used to predict the 
pertactin concentration when there are no additional proteins or species in the sample which may interfere 
with the pertactin-related fluorescence.  
PLS generally provides better prediction accuracy for regression models that correlate noisy input data 
(fluorescence) to noisy output data (Kjeldahl). Besides capturing the variance, PLS tries to describe the 
data with a small number of latent variables (LV) that maximize covariance to achieve a correlation 
between two sets of data (Wise et al., 2007).  Specifically, PLS was used to find a correlation between 




was expressed as a linear combination of three latent variables (LV).  In this model, two more samples 
were added (batches K and L).   
The R-squared value was 0.868 showing a positive linear association, between fluorescence intensities 
and PRN content. This model could be used to predict Kjeldahl values from fluorescence measurements. 
 








4.9 Dynamic fluorescence analysis using samples collected along the fermentation process  
In order to further elucidate the sources of variability between the fermentations and the effect on 
productivity, the occurrence of fluorophores were monitored for different time instances along the 
fermentation. Specifically fluorescence spectra were collected at different times for fermentation batches 
H and I. In general, all the spectra show the same pattern. The spectra obtained for batch H are shown in 
Figures 4.33 and 4.34, and for batch I are shown in Figures 4.35 and 4.36. 
The spectra measured for samples taken before the addition of the supplement (t~29 hrs) show emissions 
related to the broth components (δ, δ', γ) such as tyrosine and other amino acids, and FAD (φ) (Figure 
4.31). The peak characteristic of NAD(P)H-dehydrogenase complex (β') appears only after the 
supplement addition (t = ~29 hrs). Even though this peak appears in fermentation batches with low and 
high productivity, it was hypothesized that it might be an indicator of the existence of reactions triggered 
at the beginning of the fed-batch process that could be affecting the production of antigens, and therefore 













    
Figure 4.33 EEMs for fermenter F3 (batch H) at different fermentation times: A) 0 hrs; B) 6.22 hrs; C) 














Figure 4.34 EEMs for fermenter F6 (batch H) at different fermentation times: A) 0 hrs; B) 6.22 hrs; C) 














Figure 4.35 EEMs for fermenter F3 (batch I) at different fermentation times: A) 0 hrs; B) 6.10 hrs; C) 













Figure 4.36 EEMs for fermenter F6 (batch I) at different fermentation times: A) 0 hrs; B) 6.10 hrs; C) 









4.10 Enzyme Assay 
In an effort to identify the type of dehydrogenase that might be binding to the NAD(P)H, substrates for 
different dehydrogenases were used to measure changes in the fluorescence intensities. Because of the 
high fluorescence intensities observed in the peak characteristic of NAD(P)H-dehydrogenase, CPS-Conc-
PW was employed to conduct this analysis.  
 
 
Figure 4.37 Differences in intensities at Ex/Em = 280/460 nm (NADH-enzyme complex) between the 





























































Figure 4.37 shows the differences in the fluorescence intensities at Ex/Em = 280/460 nm between the 
intensity of CPS-Conc-PW A4 and the intensity for the same sample spiked with different substrates. For 
each enzyme substrate, three different dilution factors were used (section 3.2.1). In Figure 4.37, a dilution 
factor (DF) of 0.007 is indicated as 20, a DF of 0.013 is indicated as 40 and a DF of 0.033 is indicated as 
100. For maleate, α-ketoglutaric acid and pyruvate no significant changes were observed. In contrast, for 
oxaloacetic acid, CB1954 (substrate for ubiquinone or complex I) and INT (which get reduced with some 
enzymes as succinate dehydrogenase) significant changes were observed (Deng et al., 1992). 
Complex I, also named NADH:ubiquinone oxidoreductase, is an enzyme that participates in the first step 
of the respiratory chain of bacteria (Roos et al., 2000). It is a membrane-bound molecule that facilitates 
the transport of electrons between NADH and ubiquinone, and also the transport of protons out of 
bacterial cytosol (Roos et al., 2000). The presence of this enzyme could be explained by the existence of 
binding between the Complex I and cell membrane debris, which are filtered in the first ultrafiltration step 
of the PRN purification (CPS-Conc-PW) (Roos et al., 2000).   
As a preliminary approach, these fluorescence results provided an idea of the enzymes that could be 
present and bound to NAD(P)H, but the results are not conclusive since appreciable changes in the 
intensities were observed for more than one substrate.  Fluorescence emission of CPS-Conc-PW 
combined with NADH was also measured. After the NADH addition, the peak at Ex/Em~280/470 nm 






Figure 4.38 CPS-Conc-PW A4 and NADH. 
 
To investigate the existence of binding between PRN and NADH, a sample of pure PRN (SKA-CH2) was 






Figure 4.39 A: Spectra of SKA-CH2 G and NADH (4 µM); B: Spectra at Ex=280 nm of SKA-CH2 G (in 
solution and spiked with NADH). 
 
Figure 4.39-A shows the Trp peak corresponding to PRN at Ex/Em = 230-280/335 nm and the NADH 
peak at Ex/Em = 260-340/460 nm. The NADH peak at Ex=260 nm is not shifted to Ex=280 nm, 
indicating that binding did not occur with this antigen. On the other hand, in Figure 4.39-B it is shown the 
same spectrum at Ex=280 nm for a sample of SKA-CH2 G spiked with NADH. In this case, as expected, 
the emission of Trp is quenched by the NADH. Thus, it is possible to conclude that NADH does not bind 
to pertactin but to some other species.  
4.11 Assessment of the effect of temperature on fluorescence 
Process samples were subjected to different changes of temperature in order to assess the influence of 
storage and handling conditions.  In Figure 4.40, fluorescence spectra for two SPEP-R-Conc samples after 
changes in temperature are shown.  
A B   





Figure 4.40 A: SPEP-R-Conc A4 at three different temperatures: -30ºC, 20ºC, 90ºC   
                    B: SPEP-R-Conc A3 at three different temperatures: -30ºC, 20ºC, 90ºC 
 
The samples were left at -30ºC for 24 hrs, and at 90ºC for 1 min. The sample at -30ºC was brought to 
20ºC by rapid thawing. From the two plots it can be concluded that freezing does not have a major effect 
on the fluorescence characteristics. It is evident though that a decrease and shift of the fluorescence 
emission occurred at higher temperatures. These changes in the emission are possibly due to protein 
denaturation and unfolding of the protein (Gally et al., 1962).     
 
Figure 4.41 provides the fluorescence spectra acquired for CPS-B2-(F3) samples after cooling at 4ºC and 
raising the temperature to 25ºC, repeatedly for three days, are shown.   





Figure 4.41 A: CPS-B2-(F3) G1 after cooling (at 4°C) and back to 25ºC three times; B: CPS-B2-(F3) G2 
after cooling (at 4°C) and back to 25ºC three times. 
 
In the two plots of Figure 4.41, there are no significant differences between the original sample and the 
samples subjected to changes of temperature. Figure 4.41-B exhibits small differences in the curves, but 
these are attributed to noise. 
 




Figure 4.42 shows the spectra for a F3-S J sample after undergoing changes of 5ºC in temperature. There 
are no appreciable differences among the curves. 
4.12 Centrifugation of Samples 
In Figure 4.43, fluorescence spectra of fermenter samples for batches G1 and G2, before and after 
centrifugation are presented. This effect was investigated to assess whether stirring of the samples during 
shipment could affect the fluorescence spectra. 
  





Samples that were centrifuged are shown in red, and the original samples are marked with a blue line. The 
samples were centrifuged for 5 min at 23,000 xg. In the four plots, it is evident that a decrease in the peak 
of tryptophan and an increment of the intensity in the peak of NADH occurred after centrifugation.  
4.13 Surface Phosphophilicity Assessment 
As discussed in Chapter 1, surface phosphophilicity was investigated to assess the possibility for 
monitoring adjuvant potency during storage using a fluorescence-based assay. Surface phosphophilicity 
was assessed using the fluorogenic substrate 6,8-difluoro-4-methylumberiferyl (DiFMU) which is the 
leaving group of 6,8-difluoro-4-methylumberiferyl phosphate (DiFMUP) after hydrolysis (Zhao et al., 
2001). 
 
Figure 4.44 Reaction for DiFMUP hydrolysis. 
 
This reaction is catalyzed by alum (aluminum-contained adjuvant).  The assessment was done in a 
microplate reader with an Ex/Em=358/450 nm (characteristic excitation emission values for DiFMU) 
(Zhao et al., 2001). Three adsorbed antigens were assessed: pertactin (PRN) from batch K (February 15, 
2011); difteria toxin (DCA) from batch L (September 12, 2011); tetanus toxin (TCA) from batch M 
(August 30, 2011), and two buffers: saline and PBS. The fluorescence signals acquired are shown in 
Figure 4.43. 






Figure 4.45 DiFMUP hydrolysis. 
 
Comparing the spectra obtained from the hydrolysis of DiFMUP in the two buffers, saline and PBS, the 
differences are small. Differences were appreciable in the hydrolysis carried out in presence of the 
adsorbed adjuvants. It was expected that, in case of an efficient adsorption of the adjuvant in the antigen, 
the aluminum based adjuvant would not be capable of totally catalyzing the reaction, because its active 
sites would be cleaved in the phosphate groups of the antigen, and therefore a decrease of emission would 
be noticed.   
There is relatively more increase in intensities of PRN, saline and PBS compared to DCA and TCA. PRN 
is not entirely adsorbed whereas the adsorption of TCA and DCA are considerable. When there is free 
adjuvant, DiFMUP is hydrolyzed and that reflects in higher intensities. Unabsorbed antigen would not be 
obstructing or competing with DiFMUP.  DiFMUP hydrolysis by adjuvant is dependent on the 






Chapter 5  
Conclusions and Future Work 
The thesis presents a novel application of fluorescence spectroscopy in combination with multivariate 
analysis for diagnosing and identifying the sources of variability in a vaccine manufacturing process. The 
work also proposes the use of fluorescence for quantifying the amount of protein product in the final 
stages of the process. Attempts were made to correlate the variability in protein production with operating 
conditions of the process. Finally, the use of fluorescence for assessing efficacy of vaccines’ adjuvants 
was assessed.  
5.1 Fluorescence Analysis 
This research shows that fluorescence analysis is effective for off-line monitoring of a vaccine 
manufacturing process. By the acquisition of fluorescence signals in samples collected from different 
stages of upstream and downstream processes of a Component Pertussis vaccine, it was possible to 
identify at the same time fluorescent compounds, such as amino acids present in cells and media, 
cofactors and other nutrients, which makes this technique a valuable tool for rapid qualitative analysis. 
Fluorescence was also useful in identifying possible conformational transitions in the proteins based on 
the fluorescence emission of tryptophan (longer wavelength emission when it is more exposed to the 
environment). The fluorescence signals of enzyme cofactors were helpful for identifying the existence of 
complexes formed by the interactions between NAD(P)H and dehydrogenases, based on changes in the 
NAD(P)H emissions at lower excitations (shift from Ex=260 nm to Ex=280 nm at Em=460 nm). 
5.2 PCA analysis 
The fluorescence-based calibration models were built using multivariate statistical modelling tools, PCA 
and PLS. PCA was found to be effective for recognizing correlations between conditions at different steps 




PLS was used to predict the final protein content that can be measured with Kjeldahl analysis. PCA was 
able to extract the most important information related to the fluorophores and to compress this 
information into two or three principal components that captured most of the variance. This analysis was 
performed by gathering the fluorescence data in different arrangements: i-one matrix containing the 
spectra collected from samples of the entire process; ii-one matrix containing upstream samples; iii-three 
different matrices with downstream samples: a matrix with all samples from downstream, a matrix 
excluding downstream waste samples, and a matrix with downstream waste samples. The main idea of 
partitioning the data according to different stages of the manufacturing process was to try to find a 
possible correlation between the fluorescence corresponding to the different production steps and the final 
PRN concentration in the final stage of the purification in order to identify possible causes of yield 
variability for this antigen (pertactin). 
From the PCA analysis of the upstream matrix, it was noticed that the amount of NAD(P)H-enzyme 
complex was high in the fermenters of the batches with low productivity, suggesting that certain types of 
reactions are taking place in the fermentation steps that might be causing variability in the final yield of 
PRN. NAD(P)H acts as electron donor and oxygen acts as acceptor during oxidative phosphorylation 
needed for ATP formation. It is hypothesized that as a result of oxygen transfer limitations, NAD(P)H 
cannot be oxidized and therefore it might accumulate. Since there could be less corresponding formation 
of ATP, the production of antigens such as PRN might be diminished.   
In the analysis of the three matrices containing downstream data, it was not possible to find any pattern 
that differentiates batches with low final Kjeldahl from batches with high final Kjeldahl. In contrast to the 
upstream analysis, the peak of NAD(P)H-enzyme binding was not significant. The score plots of these set 
of data exhibited a lack of correlation between scores (samples) and productivity. For this reason, 




When performing PCA analysis in the data matrix with samples from the entire process, it was difficult to 
find a correlation with productivity. Also, the principal component related to the NAD(P)H-enzyme 
complex captured only 5.85% of the variance, compared to the principal component for the same 
fluorophore in the separated upstream data, where the variance captured was 23.85%. This suggests that 
the NADH-enzyme complex only have a significant influence in the variability of the process related to 
the upstream steps, and not to the entire process.  
5.3 Correlation among productivity and dissolved oxygen, aeration, agitation and 
supplementation time profiles recorded during fermentation 
Changes in the dissolved oxygen, aeration, agitation and supplementation time profiles were investigated 
as a possible causative of accumulation of NAD(P)H in the fermenters. These parameters are 
continuously monitored by Sanofi Pasteur in all fermentations.   
No correlation could be found between dissolved oxygen and low productivity. This parameter is 
maintained relatively constant at its set point by means of closed loop control by manipulating the 
agitation speed initially followed by the aeration rate. However, in the aeration (airflow) profiles, some 
differences among batches were found, but the relationship between the aeration levels and variability in 
protein concentration was not consistent, e.g. in some fermenters that had high final Kjeldahl, the aeration 
rate was low.  
Similarly, the relationship between agitation profiles and low productivity was not consistent. However, it 
should be remembered that the purification process is applied to one batch that is assembled together from 
four fermentation batches, so it might be possible that one or more of these batches did not provide high 





It should be noticed that to calculate the actual consumption of oxygen by the cells it would be necessary 
to measure, in addition to dissolved oxygen and aeration rates, the oxygen leaving the fermenters which 
cannot be measured in the current operation. Thus, measuring the NADH by fluorescence offers a 
distinctive advantage for identifying differences in metabolism in particular as related to consumption of 
oxygen. 
The supplementation time, or the time at which fed-batch operation starts, depends on the dissolved 
oxygen levels. When a sudden increased of the dissolved oxygen is observed, it is assumed that the 
substrate, in this case glutamine, is consumed by cells, and additional supplementation is needed. In the 
supplementation profiles, it was noticeable that some batches had a delay at the start of the fed-batch 
phase. Even though, this delay did not happen in all the fermenters with low productivity, it is important 
to highlight that the supplement addition is done manually, and it might not occur exactly at the moment 
when dissolved oxygen increases.       
To further assess changes in the cell metabolism key metabolites, such as lactate, glucose, and glutamine 
were measured at the end of different batches. For lactate and glucose levels, no appreciable correlation 
could be found between their levels and PRN productivity. In contrast, high levels of glutamine generally 
occurred for batches with low PRN productivity, i.e. low substrate consumption, which at the same time  
can be associated with oxygen consumption rates.   
Since all these measurements are performed at the end of the fermentation, an additional fluorescence 
analysis was done at different time instances along two fermentation runs. From these spectra, it was 
observed that the peak characteristic of NAD(P)H-enzyme complex appeared after the start of the 
supplement addition, i.e. fed-batch phase of cultivation. Even though this peak appears in fermentation 
batches with low and high productivity, it might be an indicator of the existence of reactions triggered at 
the beginning of the fed-batch process that could be affecting the production of antigens, and therefore the 




5.4 Regression models 
5.4.1 Regression between PCA scores obtained from fermentation samples and pertactin 
concentration 
The two regressions built between PCA scores obtained from fermentation samples and pertactin 
concentration, demonstrated that there is a statistical significant correlation between these parameters. 
One regression was made between the average of PC1 scores (inversely correlated to protein content), the 
average of PC2 scores (inversely correlated to NAD(P)H-enzyme content) in the fermenters and the final 
content of PRN measured by Kjeldahl analysis (in the last step of the purification). The goodness of fit 
was R2=0.8753. 
A second regression was built using PLS analysis. In this case, the averages of PC2 scores were 
employed. It was found that when using only six batches, the goodness of fit was high (R2=0.94), but 
when using seven batches it was R2=0.482.  
5.4.2 PLS for predicting pertactin concentration 
An additional regression model was calculated using PLS for predicting the final pertactin concentration 
from fluorescence measurements obtained from samples collected in the final step of the purification 
process. The objective was to assess whether fluorescence can predict the pertactin concentration when 
there are no additional proteins or species in the sample which may interfere with the pertactin related 
fluorescence. 
A good correlation among PRN content and fluorescence intensities was obtained, with a R2=0.868, 






5.5 Enzyme analysis 
In order to identify the enzyme dehydrogenase bound to NAD(P)H, substrates for different enzymes were 
used to measure changes in the fluorescence intensities. Changes after addition of substrates for 
oxaloacetate, ubiquinone and succinate, were the most significant. However, these results are not 
conclusive because changes were observed with more than one substrate. 
5.6 Assessment of the effect of temperature and centrifugation in fluorescence 
In the assessment of temperature, appreciable changes were observed only when the samples were heated 
up to 90ºC with a decreased in the fluorescence intensities possibly due to protein unfolding. When the 
samples where frozen, cooled and warmed, some small changes were observed attributed to noise. 
 It was also found that a decrease in the peak of tryptophan and an increment of the intensity in the peak 
of NADH occurred after centrifugation. This could be due to the exposure of Trp residues as a 
consequence to the unfolding of the protein, with a subsequent release of energy, and energy transfer to 
NADH. 
5.7 Surface phosphophilicity assessment 
Spectrofluorometry-based measurements to assess surface phosphophilicity of aluminum-based adjuvants 
in adsorbed samples were found to be sensitive. From differences in fluorescence spectra when an 
adsorbed sample is tested with a fluorogenic compound, e.g. DiFMU (leaving group after hydrolysis of 
DiFMUP), it is possible to infer the efficiency of adsorption since in case of an efficient adsorption of the 






5.8 Future Work 
While fluorescence provided indications that the variability in PRN production is related to the 
fermentation process, the sources of the variability have not been identified. 
It is proposed to identify the cause of the variability through a series of different studies that will attempt 
to map the intracellular conditions within the cells as well as the extracellular operating conditions, by 
using fluorescence and other methods. It is believed that the continuation of the current project may serve 
to develop a comprehensive approach for diagnosing variability in this and other fermentation processes. 
The following future research directions are proposed: 
1- Monitoring the dynamic evolution of fluorescence along the fermentation processes to identify 
the fermentation stage which is most responsible for the observed variability.  
2- Assessment of a fiber optic probe for online monitoring for collecting fluorescence 
measurements.  
3- Since the preliminary results revealed a correlation between large amounts of extracellular 
NADH in the fermenters with low PRN yield, the aim is to identify the sources of the difference 
in metabolic behaviour that may lead to this occurrence. As part of this study, it is proposed to 
investigate the following: (i) intracellular measurements of NAD+/NADH; (ii) intracellular 
measurements of ATP, enzymes (e.g. dehydrogenases) and organic acids that participate in the 
TCA cycle and can be correlated with the observed changes in NADH; (iii) measurements of 
ORP (oxidation redox potential) associated to NADH and ATP intracellular levels. 
4- Assessing the use of fluorescence to monitor vaccine characteristics during storage. The potential 
of fluorescence to assess aggregation and/or changes in stored formulated vaccine samples could 
be assessed by monitoring changes in the fluorescence spectra for samples stored for different 
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